Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

International Stem Cell (ISCO) Return on Equity (2016 - 2025)

International Stem Cell (ISCO) has disclosed Return on Equity for 15 consecutive years, with 0.03% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 14.0% to 0.03% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.03%, a 14.0% decrease, with the full-year FY2024 number at 0.05%, down 13.0% from a year prior.
  • Return on Equity was 0.03% for Q3 2025 at International Stem Cell, down from 0.06% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.67% in Q1 2021 to a low of 0.03% in Q3 2025.
  • A 5-year average of 0.23% and a median of 0.17% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: plummeted -100bps in 2021, then rose 16bps in 2024.
  • International Stem Cell's Return on Equity stood at 0.46% in 2021, then tumbled by -85bps to 0.07% in 2022, then skyrocketed by 187bps to 0.2% in 2023, then plummeted by -73bps to 0.05% in 2024, then crashed by -44bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Return on Equity are 0.03% (Q3 2025), 0.06% (Q2 2025), and 0.05% (Q1 2025).